- Home
- CNF vs PLUR Comparison
CNF vs PLUR Comparison
Compare CNF & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNF
- PLUR
- Stock Information
- Founded
- CNF 1999
- PLUR 2001
- Country
- CNF China
- PLUR Israel
- Employees
- CNF N/A
- PLUR N/A
- Industry
- CNF Finance: Consumer Services
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNF Finance
- PLUR Health Care
- Exchange
- CNF Nasdaq
- PLUR Nasdaq
- Market Cap
- CNF 36.9M
- PLUR 41.9M
- IPO Year
- CNF 2018
- PLUR N/A
- Fundamental
- Price
- CNF $0.42
- PLUR $4.43
- Analyst Decision
- CNF
- PLUR
- Analyst Count
- CNF 0
- PLUR 0
- Target Price
- CNF N/A
- PLUR N/A
- AVG Volume (30 Days)
- CNF 125.0K
- PLUR 15.5K
- Earning Date
- CNF 04-30-2025
- PLUR 05-13-2025
- Dividend Yield
- CNF N/A
- PLUR N/A
- EPS Growth
- CNF N/A
- PLUR N/A
- EPS
- CNF 0.08
- PLUR N/A
- Revenue
- CNF $85,661,735.00
- PLUR $1,034,000.00
- Revenue This Year
- CNF $252.34
- PLUR $472.39
- Revenue Next Year
- CNF N/A
- PLUR $254.29
- P/E Ratio
- CNF $5.32
- PLUR N/A
- Revenue Growth
- CNF N/A
- PLUR 203.23
- 52 Week Low
- CNF $0.37
- PLUR $3.33
- 52 Week High
- CNF $2.84
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- CNF 21.74
- PLUR 42.18
- Support Level
- CNF $0.65
- PLUR $4.30
- Resistance Level
- CNF $0.75
- PLUR $4.62
- Average True Range (ATR)
- CNF 0.06
- PLUR 0.29
- MACD
- CNF -0.03
- PLUR -0.08
- Stochastic Oscillator
- CNF 7.89
- PLUR 19.29
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.